The company, which is developing a device to treat heat valve diseases, secured the cash in a round backed by Elron Electronic Industries and HTGF.
Germany-based medical device developer Coramaze Technologies has closed a €4.5m ($5.1m) series A round led by technology holding company led by Elron Electronic Industries.
The round also featured corporate-backed venture capital fund High-Tech Gruenderfonds (HTGF), SeedCapital Dortmund and undisclosed private investors. It followed a €1m seed round co-led by HTGF and SeedCapital Dortmund in February 2014.
Founded in 2013, Coramaze has designed a device that will be used for the minimally invasive treatment of heart valve diseases suffered by people…
